Beyond Air makes the LungFit PH system, a medical device that generates nitric oxide from room air for hospital use. XAIR reports earnings on Wed, Nov 11, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 1 | Lake Street | Initiated | Buy |
Whale Options Flow
90DNo whale options trades in XAIR in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XAIR is in one of them and how their past XAIR trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered XAIR in an article yet. Here's the latest on the wider market.
About Beyond Air
Beyond Air is a medical device and biopharmaceutical company based in Garden City, New York. Its main product is the LungFit PH system, which makes nitric oxide from ambient air and delivers it to patients through a ventilator or directly to the lungs. Hospitals use the device to treat newborn infants with a serious breathing condition caused by high blood pressure in the lung arteries. The company is also developing related systems for lung infections and has other programs aimed at cancer and neurological conditions.
- Headquarters
- Garden City, NY